AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2,169 Cr | ₹-1,021 Cr | ₹223 Cr | ₹-1,164 Cr | ₹2,563 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹2,169 Cr |
| Mar2024 | ₹-1,021 Cr |
| Mar2023 | ₹223 Cr |
| Mar2022 | ₹-1,164 Cr |
| Mar2021 | ₹2,563 Cr |
How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,169 Cr | Positive | |
| Mar2024 | ₹-1,021 Cr | Negative | |
| Mar2023 | ₹223 Cr | Positive | |
| Mar2022 | ₹-1,164 Cr | Negative | |
| Mar2021 | ₹2,563 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹69,637.9 Cr | -2.1% | -3% | -4.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.1% |
-3% |
-4.5% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses